AIM AND SCOPE
The Journal of Pharmacology and Drug Metabolism aims to serve as an international platform for the publication of high-quality research, review articles, clinical investigations, and scholarly contributions in the fields of pharmacology, toxicology, pharmaceutics, and drug metabolism. The journal is dedicated to advancing the understanding of drug action, pharmacokinetics, pharmacodynamics, drug discovery, and metabolic pathways involved in therapeutic interventions. It seeks to promote the development of safe, effective, and innovative pharmaceutical agents through the integration of basic, translational, and clinical research.
The journal also aims to encourage interdisciplinary collaboration among researchers, clinicians, pharmacists, academicians, and healthcare professionals worldwide to facilitate the exchange of scientific knowledge and emerging advancements in pharmacological sciences. Special emphasis is placed on experimental and clinical pharmacology, drug interactions, personalized medicine, adverse drug reactions, regulatory pharmacology, and novel drug delivery systems. Through rigorous peer review and ethical publishing practices, the journal strives to disseminate impactful research that contributes to improved healthcare outcomes, rational drug therapy, and advancements in modern medicine
Scope of the journal
The Journal of Pharmacology and Drug Metabolism covers a broad spectrum of research related to pharmacology, drug discovery, drug development, pharmacokinetics, pharmacodynamics, toxicology, therapeutics, and metabolic sciences. The journal aims to provide an international platform for the publication of high-quality basic, translational, and clinical research that advances the understanding of drug action, metabolism, efficacy, safety, and therapeutic applications. The journal welcomes contributions from multidisciplinary fields that support innovation in pharmaceutical sciences and improve healthcare outcomes.
The primary areas of interest include, but are not limited to, clinical pharmacology, molecular pharmacology, neuropharmacology, cardiovascular pharmacology, endocrine pharmacology, immunopharmacology, psychopharmacology, cancer pharmacology, pediatric pharmacology, geriatric pharmacology, reproductive pharmacology, experimental pharmacology, veterinary pharmacology, pharmacogenetics, pharmacogenomics, pharmacovigilance, toxicology, drug toxicology, environmental toxicology, medicinal chemistry, pharmaceutical chemistry, natural product pharmacology, herbal medicine, biopharmaceutics, pharmaceutics, pharmaceutical biotechnology, drug formulation, nanomedicine, targeted drug delivery systems, controlled drug release, biologics, biosimilars, monoclonal antibodies, vaccines, peptide therapeutics, regenerative medicine, stem cell therapeutics, precision medicine, personalized medicine, translational medicine, clinical therapeutics, drug resistance, antimicrobial agents, antiviral therapy, antifungal agents, anti-inflammatory drugs, analgesics, anesthetics, metabolic disorders, diabetes therapeutics, obesity research, lipid metabolism, enzyme kinetics, drug metabolism, xenobiotic metabolism, cytochrome P450 studies, pharmacokinetics, pharmacodynamics, bioavailability, bioequivalence, drug interactions, adverse drug reactions, biomarker discovery, systems pharmacology, computational pharmacology, bioinformatics, artificial intelligence in drug discovery, machine learning in pharmacological research, omics technologies, proteomics, metabolomics, systems biology, clinical trials, regulatory science, pharmaceutical regulations, public health pharmacology, community pharmacy, hospital pharmacy, medication safety, drug policy, healthcare management, and emerging technologies in pharmaceutical and metabolic research.
Types of Manuscripts
The journal accepts original research articles, review articles, systematic reviews, meta-analyses, mini reviews, case reports, case series, short communications, technical notes, clinical studies, editorials, perspectives, and letters to the editor.
The scope of the journal is not limited to the topics listed above. Submissions from emerging, interdisciplinary, and innovative areas related to pharmacology, therapeutics, drug metabolism, and pharmaceutical sciences are strongly encouraged.
Global Perspective and Inclusivity
The journal encourages submissions from researchers, clinicians, academicians, and healthcare professionals worldwide. Pharmacological responses and drug metabolism can vary among populations due to genetic, environmental, lifestyle, and socio-economic factors. Therefore, studies addressing population-specific therapeutic responses, regional healthcare challenges, and global pharmacological issues are highly valued.
By promoting international collaboration and cross-disciplinary research, the journal seeks to support the development of safer, more effective, and accessible therapeutic strategies for diverse populations worldwide.
Ethical, Legal, and Regulatory Considerations
The journal recognizes the importance of ethical and regulatory standards in pharmacological and clinical research. Authors are expected to adhere to internationally accepted ethical guidelines involving human participants, animal studies, clinical trials, and pharmaceutical research.
Topics such as informed consent, patient safety, data integrity, adverse event reporting, drug regulations, clinical trial transparency, intellectual property, and equitable access to medicines are considered integral to the journal’s ethical framework.
Education and Scientific Advancement
The journal is committed to promoting education, scientific communication, and professional development in pharmacology and drug metabolism. Educational reviews, methodological updates, and evidence-based clinical insights that simplify complex pharmacological concepts and support healthcare practice are encouraged.
By disseminating scientifically rigorous and clinically relevant knowledge, the journal aims to strengthen the understanding of pharmacological sciences among researchers, clinicians, pharmacists, educators, and students.
Quality, Integrity, and Scientific Rigor
Maintaining high standards of scientific quality, integrity, and transparency is a fundamental principle of the journal. All submitted manuscripts undergo a rigorous peer review process to ensure originality, methodological accuracy, ethical compliance, and scientific relevance.
The journal encourages transparent reporting, reproducibility of findings, and adherence to established research and publication guidelines, thereby contributing to the reliability and credibility of scientific literature in pharmacology and drug metabolism.
Encouragement of Collaborative and Translational Research
The journal supports collaborative and interdisciplinary research that integrates pharmacology, medicine, biotechnology, chemistry, molecular biology, computational sciences, and clinical practice. Translational studies that bridge laboratory findings with clinical applications are particularly encouraged.
By fostering national and international collaborations, the journal aims to accelerate innovation in drug discovery, therapeutic development, and precision healthcare.
Adaptability to Emerging Scientific Developments
Pharmacology and drug metabolism are rapidly evolving fields driven by technological advancements and novel therapeutic approaches. The journal remains adaptable to these developments by continuously expanding its scope to include emerging areas such as AI-assisted drug discovery, pharmacogenomics, nanotherapeutics, precision pharmacology, and advanced drug delivery technologies.
The Journal of Pharmacology and Drug Metabolism is dedicated to advancing scientific knowledge and therapeutic innovation by maintaining a broad, inclusive, and multidisciplinary scope that supports excellence in pharmaceutical and biomedical research.
